ProCE Banner Activity

FAQs: Chemotherapy-Free Treatments for Follicular Lymphoma

Clinical Thought

In this commentary, an expert panel addresses frequently asked questions on the current and emerging roles of chemotherapy-free treatments for patients with follicular lymphoma based on the latest evidence.

Released: January 07, 2025

Expiration: January 06, 2026

Share

Faculty

Caron Jacobson

Caron Jacobson, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director, Immune Effector Cell Therapy Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Peter Martin

Peter Martin, MD

Professor of Medicine
Weill Cornell Medicine
New York, New York

Sonali M. Smith

Sonali M. Smith, MD, FASCO

Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Co-Leader, Cancer Service Line
The University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC in partnership with Follicular Lymphoma Foundation

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Genmab US, Inc.; and Ipsen Biopharmaceuticals, Inc.

AstraZeneca

Genmab US, Inc.

Ipsen Biopharmaceuticals Inc

Partners

Follicular Lymphoma Foundation

ProCE Banner

Disclosure

Primary Author

Caron Jacobson, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director, Immune Effector Cell Therapy Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Caron Jacobson, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, Appia, AstraZeneca, Bristol Myers Squibb, Caribou, Galapagos, Janssen, Kite/Gilead, Kyverna, Miltenyi, Novartis, Sana, Synthekine.

Peter Martin, MD

Professor of Medicine
Weill Cornell Medicine
New York, New York

Peter Martin, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, BeiGene, Bristol Myers Squibb, Genentech, Janssen, Merck, PeproMene.

Sonali M. Smith, MD, FASCO

Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Co-Leader, Cancer Service Line
The University of Chicago
Chicago, Illinois

Sonali M. Smith, MD, FASCO: consultant/advisor/speaker: Genmab, Ono, Regeneron.